Michel Vounatsos (Credit: World Economic Forum/Valeriano Di Domenico)

Un­der the gun with Aduhelm floun­der­ing, Bio­gen sells its stake in biosim­i­lars busi­ness for $2.3B

It turns out the Ko­rea Eco­nom­ic Dai­ly was on­to some­thing when, over the Christ­mas break, it re­port­ed that Sam­sung was in the process of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA